2,17-DICHLORO-6,13-DIMETHYL-18B,19A-DIPHENYL-8B,19ADIHYDRO-10H,18BH-(1,2,4)TRIAZOLO(4''',3''':1'',2'')QUINOLO(3'',4'':4',5')OXAZOLO(3',2'-D)-1,2,4-TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE
UNII 5P7J84859I
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,17-dichloro-6,13-dimethyl-18b,19a-diphenyl-8b,19adihydro-10h,18bh-(1,2,4)triazolo(4''',3''':1'',2'')quinolo(3'',4'':4',5')oxazolo(3',2'-d)-1,2,4-triazolo(4,3-a)(1,4)benzodiazepine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5P7J84859I.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H25Cl2N7O GVKIMVSIGPKOIB-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,17-dichloro-6,13-dimethyl-18b,19a-diphenyl-8b,19adihydro-10h,18bh-(1,2,4)triazolo(4''',3''':1'',2'')quinolo(3'',4'':4',5')oxazolo(3',2'-d)-1,2,4-triazolo(4,3-a)(1,4)benzodiazepine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.